Search
Articles
Team
Contact
Proinsulin C-peptide Researching
DISCOVER THE ART OF PUBLISHING
Articles
Team
Contact
Home
HRV
HRV
Case Studies
The effect of Proinsulin C-peptide on HRV and the LF/HF rate
Gábor Varga
-
June 21, 2021
0
Case Studies
COVID-19: INTRANASAL PROINSULIN C-PEPTIDE CASE STUDY
Gábor Varga
-
February 13, 2021
0
Coronavirus
Possible impact of intranasal proinsulin c-peptide on the course of COVID-19 infection: the role of the cholinergic anti-inflammatory pathway measured by Heart Rate Variability (HRV) and the importance of microglia, the resident immune cells in the brain
Gábor Varga
-
January 16, 2021
0
Case Studies
Intranasal Proinsulin C-peptide: PARADIGM SHIFT IN HEALTH PROTECTION AND HEALING?
Gábor Varga
-
November 6, 2020
0
Coronavirus
COVID-19: The lack of proinsulin C-peptide may be the main cause of the significantly higher mortality rate of patients with Type 1 diabetes mellitus compared to Type 2 diabetes
Gábor Varga
-
June 1, 2020
0
Coronavirus
COVID-19: O-GlcNAc and AMPKα as targets of proinsulin c peptide for preventing cytokine storm
Gábor Varga
-
May 10, 2020
0
Coronavirus
COVID-19: Methods of vagus nerve stimulation that may improve the host defense system against viral attacks
Gábor Varga
-
May 5, 2020
0
Coronavirus
May it be that central/ intranasal proinsulin C-peptide has a favorable effect by its HRV increasing ability on most of the clinical markers of the poor outcome of COVID-19? (Il-6, D-dimer, Lymphocytes)
Gábor Varga
-
April 29, 2020
0
Coronavirus
The endothelial disease that can be managed by increasing heart rate variability and the number and functions of endothelial progenitor cells
Gábor Varga
-
April 28, 2020
0
Coronavirus
Pulmonary diffusion/ gas exchange problems are dependent also on autonomic nerve functions
Gábor Varga
-
April 21, 2020
0
1
2
3
Page 1 of 3